To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Did you know that a component of your blood could be used ...

GC Biopharma (006280.KS), a global leader in plasma-derived protein therapies, today announced a significant advancement in the safety monitoring of intravenous immunoglobulin (IVIG). The company has ...

Please provide your email address to receive an email when new articles are posted on . IVIG had favorable effects on skin thickening, muscle and joint pain, and gastrointestinal symptoms of systemic ...

BOSTON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Research published in the prestigious Proceedings of the National Academy of Sciences of the United States of America (PNAS) offers hope for long-term ...

NORFOLK, Va. — After a nationwide shortage of intravenous immunoglobulin (IVIG) medication, medical centers are now getting it back in stock. Patients at Sentara Health Care can now receive their ...

Please provide your email address to receive an email when new articles are posted on . In a case study of three patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, starting ...

March 26, 2012 — The American Academy of Neurology (AAN) has published an evidence-based guideline on the use of intravenous immunoglobulin (IVIg) in the treatment of neuromuscular disorders.

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...

The FDA approved intravenous immunoglobulins (IVIG; Octagam 10%) for treating adults with dermatomyositis, a rare chronic autoimmune disease, drugmaker Octapharma announced on Tuesday. Support for the ...